Abstract
Male breast cancer (MBC) is a rare entity and overall cases reported were less than 1%.However, the incidence of MBC is rising regularly every year. Due to the lack of data on MBC, the diagnosis and treatment are tailored similar to female breast cancer. MBC risk increases with age and is usually diagnosed 10 years late as the disease progression is slow compared to female breast cancer (FBC).Commonest features of MBC is intra-ductal variant and often, upon diagnosis, the stage of the disease is already advanced. Prognosis of MBC is often poor but with the recent knowledge and advancement, new modalities of treatment are emerging.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
